INTS · Intensity Therapeutics, Inc.
$3.96
-0.04 (-1.00%)
At close · Aug 14
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our balances in cash and cash equivalents, our ability to continue our operations is dependent on obtaining additional capital, which is not within our control. As a result, we believe there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$12.93M
Shares
3.26M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-14 | 879 | $4.92 | $4,325 |
| 2026-07-13 | 268 | $4.78 | $1,281 |
| 2026-07-10 | 5,106 | $4.91 | $25,070 |
| 2026-07-09 | 1,935 | $4.90 | $9,482 |
| 2026-07-08 | 130 | $4.78 | $621 |
| 2026-07-07 | 436 | $4.52 | $1,971 |
| 2026-07-06 | 449 | $4.24 | $1,904 |
| 2026-07-02 | 3,741 | $4.15 | $15,525 |
| 2026-06-29 | 1,466 | $4.10 | $6,011 |
| 2026-06-25 | 6,488 | $4.08 | $26,471 |
| 2026-06-24 | 1,849 | $4.00 | $7,396 |
| 2026-06-23 | 7,864 | $3.94 | $30,984 |
| 2026-06-22 | 5,343 | $3.92 | $20,945 |
| 2026-06-18 | 3,649 | $3.68 | $13,428 |
| 2026-06-17 | 5,955 | $3.71 | $22,093 |
| 2026-06-16 | 2,317 | $3.93 | $9,106 |
| 2026-06-15 | 100 | $3.62 | $362 |
| 2026-06-09 | 287 | $3.78 | $1,085 |
| 2026-06-03 | 1,198 | $4.28 | $5,127 |
| 2026-05-22 | 1,498 | $4.71 | $7,056 |
| 2026-05-20 | 138 | $4.59 | $633 |
| 2026-05-18 | 526 | $4.63 | $2,435 |
Showing 1–22 of 22 settlements
Key facts
CIK
1567264
CUSIP
45828J202
13F (30d)
15 filings
15 filers
Visit website
Investor relations